InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,207.20
(
-0.27%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
-0.72%
)
Bitcoin
64,010.93
(
-1.25%
)
Post# of 2341754
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MonstaGains

Send PM Follow Ignore
Followers 214
Posts 12973
Boards Moderated 0
Alias Born 04/15/2016

MonstaGains

Re: KeepItRealistic post# 2298139

Wednesday, 08/24/2022 5:41:37 PM

Wednesday, August 24, 2022 5:41:37 PM

Post# of 2341754
Minerva Neurosciences rises 75% after Steven Cohen firm discloses large stake

Minerva Neurosciences (NASDAQ:NERV) is up 75% in Wednesday afternoon trading following an SEC filing stating that Point72 Capital Advisors has an 8.8% stake in the company.
The company reached a high today of $8.58 per share, though that is still well below the 52-week high of $16.80.
The filing, posted after Tuesday's closing bell, states that Point72 has 470K outstanding shares.
Steven A. Cohen is founder of Point72.
Minerva (NERV) is focused on treatments for central nervous system diseases. Its lead candidate, roluperidone, is in phase 3 for schizophrenia.
Seeking Alpha's Quant Rating views Minerva (NERV) as a hold with strong grades for revisions and momentum.

https://seekingalpha.com/news/3876248-minerva-neurosciences-rises-42-after-steven-cohen-firm-takes-large-stake
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up